U.S. Physical Therapy, Inc. (NYSE:USPH) declared a quarterly dividend on Wednesday, July 3rd, NASDAQ reports. Shareholders of record on Thursday, August 15th will be paid a dividend of 0.30 per share on Friday, September 13th. This represents a $1.20 annualized dividend and a yield of 0.90%. The ex-dividend date of this dividend is Wednesday, August 14th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.27.

U.S. Physical Therapy has increased its dividend by an average of 15.3% per year over the last three years and has increased its dividend every year for the last 8 years. U.S. Physical Therapy has a payout ratio of 47.8% meaning its dividend is sufficiently covered by earnings. Research analysts expect U.S. Physical Therapy to earn $3.21 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 37.4%.

Shares of NYSE USPH opened at $133.38 on Tuesday. The firm has a market cap of $1.68 billion, a PE ratio of 50.33, a PEG ratio of 3.99 and a beta of 1.13. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.18 and a quick ratio of 1.18. The firm has a fifty day moving average of $126.06. U.S. Physical Therapy has a fifty-two week low of $98.69 and a fifty-two week high of $135.01.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.81 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.81. The firm had revenue of $126.40 million during the quarter, compared to analysts’ expectations of $124.86 million. U.S. Physical Therapy had a return on equity of 19.50% and a net margin of 6.22%. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.73 EPS. As a group, equities research analysts expect that U.S. Physical Therapy will post 2.92 earnings per share for the current fiscal year.

Several equities analysts have weighed in on the company. Zacks Investment Research raised U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $127.00 price objective for the company in a report on Friday, April 26th. Barrington Research reaffirmed a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, May 3rd. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. U.S. Physical Therapy currently has an average rating of “Buy” and a consensus target price of $113.54.

In related news, CFO Lawrance W. Mcafee sold 2,500 shares of the business’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $131.50, for a total transaction of $328,750.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Christopher J. Reading sold 19,860 shares of the business’s stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $119.36, for a total value of $2,370,489.60. The disclosure for this sale can be found here. 2.50% of the stock is currently owned by insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: When is a capital gain realized?

Dividend History for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.